Coronary artery disease in dialysis patients

Contributions to Nephrology

Volumn 124, Issue , 1998, Pages 1-17

  Wizemann, V ^a  

^a Georg Haas Dialysezentrum   (Germany)

Author keywords

Atherosclerosis; Coronary artery disease; Dialysis; Renal anemia; rHu erythropoietin

Indexed keywords

ADULT; ANGIOCARDIOGRAPHY; CASE REPORT; CHRONIC KIDNEY FAILURE; CORONARY ARTERY BYPASS GRAFT; CORONARY ARTERY DISEASE; ELECTROCARDIOGRAPHY; FOLLOW UP; HUMAN; MALE; RENAL REPLACEMENT THERAPY; REVIEW; RISK ASSESSMENT; TRANSLUMINAL CORONARY ANGIOPLASTY; TREATMENT OUTCOME;

ADULT; ANGIOPLASTY, TRANSLUMINAL, PERCUTANEOUS CORONARY; CORONARY ANGIOGRAPHY; CORONARY ARTERY BYPASS; CORONARY DISEASE; ELECTROCARDIOGRAPHY; FOLLOW-UP STUDIES; HUMANS; KIDNEY FAILURE, CHRONIC; MALE; RENAL DIALYSIS; RISK ASSESSMENT; TREATMENT OUTCOME;

EID: 0032239853     PISSN: 03025144     EISSN: None     Source Type: Book Series    
DOI: 10.1159/000059929     Document Type: Article

References (52)

1. Wing AJ, Brunner FP, Brynger H, Jacobs C, Kramer P, Selwood NH, Gretz N: Cardiovascular related causes of death and the fate of patients with renovascular disease. Contrib Nephrol. Basel, Karger, 1984, vol 41, pp 306-311.
2. Held P, Levin N, Port F: Cardiac disease in chronic uremia: An overview; in Parfrey PS, Harnett JD (eds): Cardiac dysfunction in chronic uremia. New York, Kluwer Academic Publishers, 1972, pp 3-17.
3. Ritz E, Lippert J, Keller Ch: Hypertension, cardiovascular complications and survival in diabetic patients on maintenance hemodialysis. Nephrol Dial Transplant 1995;10(suppl 7):43-46.
4. Report on Management of Renal Failure in Europe, XXIV, 1993. Nephrol Dial Transplant 1995;10(suppl 5):11.
5. London G, Fabiani F: Left ventricular dysfunction in end-stage renal disease. Echocardiographic insights; in Parfrey PS, Harnett JD (eds): Cardiac Dysfunction in Chronic Uremia. New York, Kluwer Academic Publishers, 1992.
6. Silverberg JS, Barre PE, Prichard S, Snidermann A: Impact of left ventricular hypertrophy on survival in end-stage renal disease. Kidney Int 1989;36:286-290.
7. Schwartzkopff B, Motz W, Frenzel H, Vogt M, Knauer S, Strauer B: Structural and functional alterations of the intramyocardial arterioles in patients with arterial hypertension. Circulation 1993;88:993-1003.
8. Mall G, Huther W, Schneider J, Lundin P, Ritz E: Diffuse intermyocardiocytic fibrosis in uraemic patients. Nephrol Dial Transplant 1990;5:39-44.
9. Mall G, Rambauseck M, Neumeister A, Kollmar S, Vetterlein F, Ritz E: Myocardial interstitial fibrosis in experimental uremia. Implications for cardiac compliance. Kidney Int 1988;33:804-811.
10. Amann K, Wiest G, Neusüss R, Irzyniec T, Ritz E: Vascular hypertrophy is independent of hypertension. Am J Hypertens 1995;8:409-417.
11. Fuster V, Badimon L, Bachmon J, Chesebro J: The pathogenesis of coronary artery disease and the acute coronary syndrome. N Engl J Med 1992;326:242-250.
12. Bennett M, Evan G, Schwartz G: Apoptosis of human vascular smooth muscle cells derived from normal vessels and coronary atherosclerotic plaques. J Clin Invest 1995;95:2266-2274.
13. Rostand S, Sanders C, Rutsky E: Cardiac calcification in uremia. Contrib Nephrol. Basel, Karger, 1994, vol 106. pp 26-29.
14. Kramer W, Wizemann V, Lämmlein G, et al: Cardiac dysfunction in patients on maintenance hemodialysis. Contrib Nephrol. Basel, Karger, 1986, vol 52, pp 110-124.
15. Manske C, Thomas W, Wany Y, Wilson R: Screening diabetic transplant candidates for coronary artery disease: Identification of a low risk subgroup. Kidney Int 1993;44:617-627.
16. Lippert J, Ritz E, Schwarzbeck A, Schneider P: The rising tide of end-stage renal failure from diabetic nephrology type II on epidemiology analysis. Nephrol Dial Transplant 1995;10:462-467.
17. Manske C, Wang Y, Rector T, Wilson R, White C: Coronary revascularization in insulin-dependent diabetic patients with chronic renal failure. Lancet 1992;340:998-1002.
18. Rostand SG, Gretes JC, Krik KA, Rutsky EA, Andreoli TE: Ischemic heart disease in patients with uremia undergoing maintenance hemodialysis. Kidney Int 1979;16:600-611.
19. Rostand SG, Kirk KA, Rutsky EA: The epidemiology of coronary artery disease in patients on maintenance hemodialysis: Implications for management. Contrib Nephrol. Basel, Karger, 1986, vol 52, pp 34-41.
20. Rostand SG, Rutsky EA: Ischemic heart disease in chronic renal failure: Management considerations. Semin Dial 1989;2:98-101.
21. Roig E, Betriu A, Castaner A, Magrina J, Sanz G, Navarra-Lopez F: Disabling angina pectoris with normal coronary arteries in patients undergoing hemodialysis. Am J Med 1981;71:437-444.
22. Hässler R, Höfling B, et al: Koronare Herzkrankheit und Herzklappenerkrankungen bei Patienten mit terminaler Niereninsuffizienz. Dtsch Med Wochenschr 1987;112:714-718.
23. Rutsky E, Rostand S: The management of coronary artery disease in patients with end-stage renal disease; in Parfrey PS, Harnett JD (eds): Cardiac Dysfunction in Chronic Uremia. New York, Kluwer Academic, 1992, pp 231-246.
24. Brown KA, Rimmer J, Haish C: Non-invasive cardiac risk stratification of diabetic and non-diabetic uremic renal allograft candidates using dipyridamole-thallium 201 imaging and radionuclide ventriculography. Am J Cardiol 1989;64:1017-1021.
25. Garvin PJ, Hoff J, Marsh J, Byers SL, Chaitman B: Prognostic value of intravenous dipyridamolethallium imaging in patients with diabetes mellitus considered for renal transplantation. Am J Cardiol 1990;65:1459-1463.
26. Brown J, Vites N, Testa H, Prescott M, Hunt L, Gokal R, Mallick N: Value of thallium myocardial imaging in the prediction of future cardiovascular events in patients with end-stage renal failure. Nephrol Dial Transplant 1993;8:433-437.
27. Derfler K, Kletter K, Balcke P, Heinz G, Dudzak R: Predictive value of thallium-201-dipyridamole myocardial stress scintigraphy in chronic hemodialyis patients and transplant recipients. Clin Nephrol 1991;36:192-202.
28. Rao V, Dick C, White C, Herzog C: The usefulness of dobutamine stress echocardiography in the detection of significant coronary lesions of ESRD patients undergoing pre-transplant evaluation (abstract). J Am Soc Nephrol 1993;4:958.
29. Nally J, Mairesse G, Grimm R, et al: Dobutamine echocardiography is an effective screening tool for coronary artery disease in ESRD. J Am Soc Nephrol 1993;4:13.
30. Ritz E, Querfeld U: Atherogenesis - Is it accelerated in uremia? Semin Dial 1989;2:252-256.
31. Randomized trial of cholesterol lowering in 4,444 patients with coronary heart disease: The Scandinavian Simvastatin Survival Study (4S). Lancet 1994;344:1383-1389.
32. Yusuf S, Peto J, Lewis J, Collins R, Sleight A: Beta-blockage during and after myocardial infarction -An overview of randomized trials. Prog Cardiovasc Dis 1985;27:335-371.
33. Fuster V: Lewis A Common Memorial Lecture: Mechanism leading to myocardial infarction. Insights from studies of vascular biology. Circulation 1994;90:2126-2146.
34. Fuster V, Dyken ML, Vokonas P, Henneckens C: Aspirin as a therapeutic agent in cardiovascular disease. Circulation 1993;87:659-675.
35. Raine AEG: Acquired aortic stenosis in dialysis patients. Nephron 1994;68:155-164.
36. Wizemann V, Kaufmann J, Kramer W: Effect of erythropoietin on ischemia tolerance in anaemic hemodialysis patients with confirmed coronary artery disease. Nephron 1992;62:161-165.
37. Wizemann V: Points to remember when dialyzing the patient with coronary disease. Nephrol Dial Transplant, in press.
38. Kramer W, Wizemann V, Thormann J, Kindler M, Müller K, Schlepper M: Cardiac dysfunction in patients on maintenance hemodialysis. The importance of associated heart diseases in determining alterations of cardiac performance. Contrib Nephrol. Basel, Karger, 1986, vol 52, pp 97-109.
39. Koch M, Thomas B, Tschöpe W, Ritz E: Survival and predictors of death in dialyzed diabetic patients. Diabetologia 1993;36:1113-1117.
40. Graft Surgery Trialist. Lancet 1994;344:563-570.
41. Opsahl J, Husebye D, Helseth H, Collin A: Coronary artery bypass surgery in patients on maintenance dialysis: Long-term survival. Am J Kidney Dis 1988;12:271-274.
42. Deutsch E, Bernstein R, Adonizio V, Kussmaul W: Coronary artery bypass surgery in patients on chronic hemodialysis: A case-control study. Ann Intern Med 1989;110:369-372.
43. Rostand S, Kirk K, Rutzky E, Pacifico A: Results of coronary bypass grafting in end-stage renal disease. Am J Kidney Dis 1988;12:266-270.
44. Ivens K, Heering P, Koch M, Leschke M, Schulte H, Grabensee B: Indications and outcome of cardiosurgery in dialysis patients; in Timio M, Wizemann V, Venazi S (eds): Cardionephrology 3. Cosenza, Editoriale Bios, 1995, pp 145-149.
45. De Meyer M, Wyns W, Dion R, Khoury G, Pirson Y, van Ipersele de Strihou C: Myocardial revascularization in patients on renal replacement therapy. Clin Nephrol 1991;36:147-151.
46. Kahn J, Rutherford B, McConahay D, Johnson W, Giorgi L, Hartzler G: Shrot- and long-term outcome of percutaneous transluminal angioplasty in chronic dialysis patients. Am Heart J 1990;119:484-489.
47. Reusser L, Osborn L, White H, Sexon R, Crawford M: Increased morbidity after coronary angioplasty in patients on chronic hemodialysis. Am J Cardiol 1994;73:965-966.
48. Ahmed W, Shubrooks S, Gibson M, Bain D, Bittl J: Complications and long-term outcome after percutaneous coronary angioplasty in chronic hemodialysis patients. Am Heart J 1994;128:252-255.
49. Rinehart A, Herzog C, Collins H, Flack J, Ma J, Opsahl J: A comparison of coronary angioplasty and coronary artery bypass grafting outcome in chronic dialysis patients. Am J Kidney Dis 1995;25:281-290.
50. Shepherd J, Cobbe S, Ford I, et al: Prevention of coronary heart disease with pravastatin in men with hypercholesterolemia. N Engl J Med 1995;333:1301-1307.
51. Kakinuma Y, Kawamura T, Bills T, Yoshioka T, Ichikawa I, Fogo A: Blood pressure independent effect of angiotensin inhibition on vascular lesions of chronic renal failure. Kidney Int 1992;42:46-55.
52. Fliser D, Schweizer C, Mann J, Ritz E: How many patients die with pre-terminal renal failure? Nephrol Dial Transplant 1991;10:600.